Andrew Gwynne – 2016 Parliamentary Question to the Department of Health
The below Parliamentary question was asked by Andrew Gwynne on 2016-01-12.
To ask the Secretary of State for Health, what steps he is taking to reduce errors in the dispensing of aseptic pharmaceutical products.
George Freeman
The manufacturing process for aseptic pharmaceutical products by licensed Specials manufacturers is subject to Good Manufacturing Practice and Good Pharmacovigilance Practice – both of which are monitored by the Medicines and Healthcare products Regulatory Agency.
Aseptic compounding in pharmacies and health clinics under the section 10 exemption of the Medicines Act 1968 is carried out under the supervision of a pharmacist and is subject to periodic audits by National Health Service quality assurance pharmacists.
